Carbamazepine Treatment for Cocaine Dependence - 5

This study has been completed.

First Received: September 20, 1999 Last Updated: June 23, 2005 History of Changes

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Pennsylvania
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000191

Purpose

The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: Carbamazepine	Phase II

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Carbamazepine Treatment for Cocaine Dependence

Resource links provided by NLM:

Drug Information available for: Cocaine hydrochloride Carbamazepine

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	21 Years to 51 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000191

Locations

United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Pennsylvania

Investigators

Principal Investigator:

James Cornish, M.D.

University of Pennsylvania

More Information

No publications provided

Study ID Numbers:	NIDA-00144-5, K20-00144-5
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000191 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders
Tranquilizing Agents
Psychotropic Drugs
Disorders of Environmental Origin
Central Nervous System Depressants
Antimanic Agents
Carbamazepine

Mental Disorders
Analgesics, Non-Narcotic
Substance-Related Disorders
Analgesics
Peripheral Nervous System Agents
Cocaine
Anticonvulsants

Additional relevant MeSH terms:

Cocaine-Related Disorders
Tranquilizing Agents
Physiological Effects of Drugs
Psychotropic Drugs
Central Nervous System Depressants
Disorders of Environmental Origin
Antimanic Agents
Pharmacologic Actions
Carbamazepine

Mental Disorders
Analgesics, Non-Narcotic
Sensory System Agents
Therapeutic Uses
Substance-Related Disorders
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents
Anticonvulsants

ClinicalTrials.gov processed this record on July 02, 2009